GLP-1: Barclays on why 2025 could be an inflection point
Investing.com — The landscape of GLP-1 drugs, which are widely recognized for their efficacy in weight loss and diabetes management, is poised
Investing.com — The landscape of GLP-1 drugs, which are widely recognized for their efficacy in weight loss and diabetes management, is poised
Investing.com — The U.S. housing market is expected to see mild improvements in 2025, but elevated mortgage rates and affordability challenges will continue
Investing.com — In its report titled “2025 Global Real Estate Outlook,” RBC Capital Markets said it anticipates diverging paths for Canadian (CDN)
Investing.com — In a recent note, Bank of America outlined 14 key lessons from 2024 that investors should keep in mind as
TOKYO (Reuters) – Honda (NYSE:HMC) and Nissan (OTC:NSANY) are considering producing vehicles in one another’s factories as part of their
By Jody Godoy (Reuters) – Alphabet (NASDAQ:GOOGL)’s Google proposed on Friday a loosening of its agreements with Apple (NASDAQ:AAPL) and others to set
TORONTO (Reuters) – A U.S. judge ruled on Friday in favor of Meta (NASDAQ:META) Platform Inc’s WhatsApp in a lawsuit accusing Israel’s
Investing.com — Qualcomm scored a major legal victory on Friday when a U.S. jury determined that the company didn’t violate its licensing
By David Shepardson WASHINGTON (Reuters) – A partial government shutdown could cost the U.S. travel industry $1 billion per week and lead to
By Raphael Satter and AJ Vicens WASHINGTON (Reuters) – Officials in the United States and Israel have denied reports their countries had signed